Blood vessels engineered from human cells [3] (multiple letters)

Lancet

Volumn 366, Issue 9489, 2005, Pages 891-892

  Kassem, Moustapha ^a   Burns, Jorge ^a   Abd Allah, Basem ^a   Torensma, Ruurd ^b   Niklason, Laura E ^c   Counter, Christopher M ^c  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

BLOOD VESSEL; CELL DIFFERENTIATION; EPIGENETICS; GENE EXPRESSION; GENE INDUCTION; GENETIC DISORDER; HUMAN; HUMAN CELL; LETTER; PHENOTYPE; PRIORITY JOURNAL; TISSUE ENGINEERING;

EID: 24644450729     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67311-4     Document Type: Letter

References (5)

1. M Poh M Boyer A Solan Blood vessels engineered from human cells Lancet 365 2005 2122 2124
2. JL Simonsen C Rosada N Serakinci Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells Nat Biotechnol 6 2002 592 596
3. N Serakinci P Guldberg JS Burns Adult human mesenchymal stem cell as a target for neoplastic transformation Oncogene 23 2004 5095 5098
4. JS Burns BM Abdallah P Guldberg Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells Cancer Res 65 2005 3126 3135
5. M Kassem B Abdallah Z Yu The use of hTERT-immortalized cells in tissue engineering Cytotechnology 45 2004 39 46